AJR ARRS Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maurea, S.
Right arrow Articles by Salvatore, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maurea, S.
Right arrow Articles by Salvatore, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

American Journal of Roentgenology, Vol 173, 25-29, Copyright © 1999 by American Roentgen Ray Society


ARTICLES

Imaging of adrenal tumors using FDG PET: comparison of benign and malignant lesions

S Maurea, C Mainolfi, L Bazzicalupo, MR Panico, C Imparato, B Alfano, M Ziviello and M Salvatore
Medicina Nucleare e Radiodiagnostica, Istituto Nazionale dei Tumori, Naples, Italy.

OBJECTIVE: The aim of this study was to differentiate benign from malignant adrenal tumors using positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG) in patients with unilateral adrenal masses originally detected by CT or MR imaging. CONCLUSION: PET imaging with FDG can metabolically characterize adrenal masses. Abnormally increased FDG uptake in adrenal malignancies allows one to differentiate these abnormalities from benign lesions. Whole-body PET can also reveal extraadrenal tumor sites in patients with malignant tumors, using a single imaging technique for accurate disease staging.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
RadiologyHome page
J. F. Faria, S. M. Goldman, J. Szejnfeld, H. Melo, C. Kater, P. Kenney, M. P. Huayllas, G. Demarchi, V. V. Francisco, C. Andreoni, et al.
Adrenal Masses: Characterization with in Vivo Proton MR Spectroscopy Initial Experience
Radiology, December 1, 2007; 245(3): 788 - 797.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. Singh, B. Camazine, Y. Jadhav, R. Gupta, P. Mukhopadhyay, A. Khan, R. Reddy, Q. Zheng, D. D. Smith, R. Khode, et al.
Endoscopic Ultrasound As a First Test for Diagnosis and Staging of Lung Cancer: A Prospective Study
Am. J. Respir. Crit. Care Med., February 15, 2007; 175(4): 345 - 354.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
S. Chong, K. S. Lee, H. Y. Kim, Y. K. Kim, B.-T. Kim, M. J. Chung, C. A Yi, and G. Y. Kwon
Integrated PET-CT for the Characterization of Adrenal Gland Lesions in Cancer Patients: Diagnostic Efficacy and Interpretation Pitfalls
RadioGraphics, November 1, 2006; 26(6): 1811 - 1824.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. C. Mackie, B. L. Shulkin, R. C. Ribeiro, F. P. Worden, P. G. Gauger, R. J. Mody, L. P. Connolly, G. Kunter, C. Rodriguez-Galindo, J. W. Wallis, et al.
Use of [18F]Fluorodeoxyglucose Positron Emission Tomography in Evaluating Locally Recurrent and Metastatic Adrenocortical Carcinoma
J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2665 - 2671.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Allolio and M. Fassnacht
Adrenocortical Carcinoma: Clinical Update
J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2027 - 2037.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
M. A. Blake, J. M. A. Slattery, M. K. Kalra, E. F. Halpern, A. J. Fischman, P. R. Mueller, and G. W. Boland
Adrenal Lesions: Characterization with Fused PET/CT Image in Patients with Proved or Suspected Malignancy--Initial Experience
Radiology, March 1, 2006; 238(3): 970 - 977.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
U. Metser, E. Miller, H. Lerman, G. Lievshitz, S. Avital, and E. Even-Sapir
18F-FDG PET/CT in the Evaluation of Adrenal Masses
J. Nucl. Med., January 1, 2006; 47(1): 32 - 37.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
M. A. Blake, M. K. Kalra, A. T. Sweeney, B. C. Lucey, M. M. Maher, D. V. Sahani, E. F. Halpern, P. R. Mueller, P. F. Hahn, and G. W. Boland
Distinguishing Benign from Malignant Adrenal Masses: Multi-Detector Row CT Protocol with 10-Minute Delay
Radiology, December 21, 2005; (2005) 2382041514.
[Abstract] [Full Text]


Home page
JNMHome page
R. Kumar, Y. Xiu, J. Q. Yu, A. Takalkar, G. El-Haddad, S. Potenta, J. Kung, H. Zhuang, and A. Alavi
18F-FDG PET in Evaluation of Adrenal Lesions in Patients with Lung Cancer
J. Nucl. Med., December 1, 2004; 45(12): 2058 - 2062.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
M. A. Blake, A. T. Sweeney, M. K. Kalra, and M. M. Maher
Collision Adrenal Tumors on PET/CT
Am. J. Roentgenol., September 1, 2004; 183(3): 864 - 865.
[Full Text] [PDF]


Home page
Endocr. Rev.Home page
G. Mansmann, J. Lau, E. Balk, M. Rothberg, Y. Miyachi, and S. R. Bornstein
The Clinically Inapparent Adrenal Mass: Update in Diagnosis and Management
Endocr. Rev., April 1, 2004; 25(2): 309 - 340.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
S. D. Paulsen, H. V. Nghiem, M. Korobkin, E. M. Caoili, and E. J. Higgins
Changing Role of Imaging-Guided Percutaneous Biopsy of Adrenal Masses: Evaluation of 50 Adrenal Biopsies
Am. J. Roentgenol., April 1, 2004; 182(4): 1033 - 1037.
[Abstract] [Full Text] [PDF]


Home page
ImagingHome page
S M Lyon and M J Lee
Imaging the non-hyperfunctioning adrenal mass
Imaging, April 1, 2002; 14(2): 137 - 146.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
J.F. Vansteenkiste
Imaging in lung cancer: positron emission tomography scan
Eur. Respir. J., February 1, 2002; 19(35_suppl): 49S - 60s.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
M. Yun, W. Kim, N. Alnafisi, L. Lacorte, S. Jang, and A. Alavi
18F-FDG PET in Characterizing Adrenal Lesions Detected on CT or MRI
J. Nucl. Med., December 1, 2001; 42(12): 1795 - 1799.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
W. W. Mayo-Smith, G. W. Boland, R. B. Noto, and M. J. Lee
State-of-the-Art Adrenal Imaging
RadioGraphics, July 1, 2001; 21(4): 995 - 1012.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
S. Maurea, M. Klain, C. Mainolfi, M. Ziviello, and M. Salvatore
The Diagnostic Role of Radionuclide Imaging in Evaluation of Patients with Nonhypersecreting Adrenal Masses
J. Nucl. Med., June 1, 2001; 42(6): 884 - 892.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
J.F. Vansteenkiste and S.G. Stroobants
The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology
Eur. Respir. J., April 1, 2001; 17(4): 802 - 820.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Roentgen Ray Society.